Other
Intraarticular
1
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Intraarticular is an early-stage landscape with 1 program across 3 companies. The most active players are Taiwan Bio Therapeutics Inc., Revance Therapeutics, Inc., 4Moving Biotech.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
11
clinical trials
Completed4 · 36%
Unknown status3 · 27%
Terminated2 · 18%
Withdrawn1 · 9%
Recruiting1 · 9%
Clinical Trials
Trial Activity
11 trials
Efficacy Study of Continuous Intraarticular Infusion in Patients Undergoing Arthroscopic Knee and Shoulder Operations
Terminated·—·Phase 4·NCT00314457·16 enrolled
Radiofrequency Versus Intraarticular Local Anesthestic and Steroids Injection for Chronic Hip Pain.
Unknown status·—·Phase 4·NCT03985280·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)